Dr. David Easson is a key member on the Zea Science advisory board and brings a wealth of biotech and manufacturing expertise to round out the Zea team.
After earning his undergraduate degree in Chemical Engineering from the University of South Carolina, Dr. Easson went on to complete an ScD and a post-doc in Biochemical Engineering at MIT. And, while at MIT, he co-founded Alpha-Beta Technology, a biopharmaceutical company that went public in 1992.
From 1999 to today, Dr. Easson has worked at several large biotech firms as well as a research university (WPI).
He currently serves as the Chief Manufacturing Officer at Solarea Bio in Cambridge, MA.
Dr. Easson believes in the promise that plant-derived drug discovery and manufacturing holds for the future.